Skip to main content
. 2023 Apr 18;55(1):2199219. doi: 10.1080/07853890.2023.2199219

Figure 4.

Figure 4.

Possibility of PA-TACE-insensitive, recurrence-free survival (RFS) and overall survival (OS) of hepatocellular carcinoma patients after hepatic resection (HR) alone or with postoperative adjuvant transarterial chemoembolization (PA-TACE) among total 749 patients: comparison of possibility of PA-TACE-insensitive, RFS, or OS (A–C) in the low score group (n = 338), (D–F) in the high score group (n = 411). The log-rank test was used to determine significant differences between Kaplan–Meier curves.